Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?
暂无分享,去创建一个
C. Pirich | W. Hitzl | H. Gallowitsch | G. Rendl | Gregor Schweighofer-Zwink | S. Sorko | Diana Reisinger